Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024 Read more
Bill’s CEO says it’s not healthy for entrepreneurs or society to focus on wealth creation over innovation Read more